Reactive sulfur and selenium species in the regulation of bone homeostasis

Sies, 2020, Reactive oxygen species (ROS) as pleiotropic physiological signalling agents, Nat. Rev. Mol. Cell Biol., 21, 363, 10.1038/s41580-020-0230-3 Brieger, 2012, Reactive oxygen species: from health to disease, Swiss Med. Wkly., 142 Deffert, 2012, Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells, J. Pathol., 228, 341, 10.1002/path.4061 Wauquier, 2009, Oxidative stress in bone remodelling and disease, Trends Mol. Med., 15, 468, 10.1016/j.molmed.2009.08.004 Wang, 2003, The gasotransmitter role of hydrogen sulfide, Antioxidants Redox Signal., 5, 493, 10.1089/152308603768295249 Zhao, 2014, Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications, Chem. Commun., 50, 11788, 10.1039/C4CC00968A Szabo, 2018, A timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator, Biochem. Pharmacol., 149, 5, 10.1016/j.bcp.2017.09.010 Wang, 2012, Physiological implications of hydrogen sulfide: a whiff exploration that blossomed, Physiol. Rev., 92, 791, 10.1152/physrev.00017.2011 Liu, 2014, Hydrogen sulfide maintains mesenchymal stem cell function and bone homeostasis via regulation of Ca2+ channel sulfhydration, Cell Stem Cell, 15, 66, 10.1016/j.stem.2014.03.005 Gambari, 2017, Distinctive expression pattern of cystathionine-beta-synthase and cystathionine-gamma-lyase identifies mesenchymal stromal cells transition to mineralizing osteoblasts, J. Cell. Physiol., 232, 3574, 10.1002/jcp.25825 Behera, 2019, Role of hydrogen sulfide in the musculoskeletal system, Bone, 124, 33, 10.1016/j.bone.2019.03.034 Gambari, 2019, Hydrogen sulfide in bone tissue regeneration and repair: state of the art and new perspectives, Int. J. Mol. Sci., 20, 10.3390/ijms20205231 Hao, 2021, Association of hydrogen sulfide with femoral bone mineral density in osteoporosis patients: a preliminary study, Med. Sci. Monit., 27, 10.12659/MSM.929389 Song, 2022, Advances in pathogenesis and therapeutic strategies for osteoporosis, Pharmacol. Ther., 10.1016/j.pharmthera.2022.108168 Yao, 2011, Selenium, iodine, and the relation with Kashin-Beck disease, Nutrition, 27, 1095, 10.1016/j.nut.2011.03.002 Ren, 2007, Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats, Osteoarthr. Cartil., 15, 1171, 10.1016/j.joca.2007.03.013 Medeiros, 2016, Copper, iron, and selenium dietary deficiencies negatively impact skeletal integrity: a review, Exp. Biol. Med., 241, 1316, 10.1177/1535370216648805 Zeng, 2013, Selenium in bone health: roles in antioxidant protection and cell proliferation, Nutrients, 5, 97, 10.3390/nu5010097 Pietschmann, 2014, Selenoprotein P is the essential selenium transporter for bones, Metallomics, 6, 1043, 10.1039/C4MT00003J Seleno-L-cystine, 2019, 1 L-cystine, 2021, 1 Wessjohann, 2007, Selenium in chemistry and biochemistry in comparison to sulfur, Biol. Chem., 388, 997, 10.1515/BC.2007.138 Iwaoka, 2013, From sulfur to selenium. A new research arena in chemical biology and biological chemistry, Curr. Chem. Biol., 7, 2, 10.2174/2212796811307010002 Battin, 2009, Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms, Cell Biochem. Biophys., 55, 1, 10.1007/s12013-009-9054-7 Baker, 2001, Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization, J. Bacteriol., 183, 1961, 10.1128/JB.183.6.1961-1973.2001 Zhang, 2020, A novel thioredoxin-dependent peroxiredoxin (TPx-Q) plays an important role in defense against oxidative stress and is a possible drug target in babesia microti, Front. Vet. Sci., 7, 76, 10.3389/fvets.2020.00076 Lazard, 2015, Trans-sulfuration pathway seleno-amino acids are mediators of selenomethionine toxicity in Saccharomyces cerevisiae, J. Biol. Chem., 290, 10741, 10.1074/jbc.M115.640375 Kearns, 2008, Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease, Endocr. Rev., 29, 155, 10.1210/er.2007-0014 Ha, 2004, Reactive oxygen species mediate RANK signaling in osteoclasts, Exp. Cell Res., 301, 119, 10.1016/j.yexcr.2004.07.035 Domazetovic, 2017, Oxidative stress in bone remodeling: role of antioxidants, Clin. Cases Mineral Bone Metabol., 14, 209, 10.11138/ccmbm/2017.14.1.209 Rapposelli, 2017, A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions, Sci. Rep., 7, 10.1038/s41598-017-11608-z Gambari, 2014, Sodium hydrosulfide inhibits the differentiation of osteoclast progenitor cells via NRF2-dependent mechanism, Pharmacol. Res., 87, 99, 10.1016/j.phrs.2014.06.014 Xu, 2011, Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis, Free Radic. Biol. Med., 50, 1314, 10.1016/j.freeradbiomed.2011.02.016 Gennari, 2020, Emerging therapeutic targets for osteoporosis, Expert Opin. Ther. Targets, 24, 115, 10.1080/14728222.2020.1726889 Moon, 2012, Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation, Biochem. Biophys. Res. Commun., 418, 247, 10.1016/j.bbrc.2012.01.005 Wang, 2019, Association between dietary selenium intake and the prevalence of osteoporosis: a cross-sectional study, BMC Muscoskel. Disord., 20, 585, 10.1186/s12891-019-2958-5 Pedrera-Zamorano, 2012, The protective effect of calcium on bone mass in postmenopausal women with high selenium intake, J. Nutr. Heath Aging, 16, 743, 10.1007/s12603-012-0071-7 Yu, 2018, Polysaccharide-protein complex-decorated selenium nanosystem as an efficient bone-formation therapeutic, J. Mater. Chem. B, 6, 5215, 10.1039/C8TB01084F Khosla, 2012, Estrogen and the skeleton, Trends Endocrinol. Metabol., 23, 576, 10.1016/j.tem.2012.03.008 Grassi, 2016, Hydrogen sulfide is a novel regulator of bone formation implicated in the bone loss induced by estrogen deficiency, J. Bone Miner. Res., 31, 949, 10.1002/jbmr.2757 Ma, 2019, Hydrogen sulfide is a novel regulator implicated in glucocorticoids-inhibited bone formation, Aging, 11, 7537, 10.18632/aging.102269 Muthusami, 2005, Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats, Clin. Chim. Acta, 360, 81, 10.1016/j.cccn.2005.04.014 Ulas, 2011, Effects of 17beta-estradiol and vitamin E treatments on blood trace element and antioxidant enzyme levels in ovariectomized rats, Biol. Trace Elem. Res., 139, 347, 10.1007/s12011-010-8669-2 Zhou, 2012, Estrogen status alters tissue distribution and metabolism of selenium in female rats, J. Nutr. Biochem., 23, 532, 10.1016/j.jnutbio.2011.02.008 Freitas, 2012, Radioprotective effect of sodium selenite on bone repair in the tibia of ovariectomized rats, Braz. Dent. J., 23, 723, 10.1590/S0103-64402012000600017 Kim, 2018, Causes of hyperhomocysteinemia and its pathological significance, Arch. Pharm. Res., 41, 372, 10.1007/s12272-018-1016-4 Kožich, 2019, Metabolism of sulfur compounds in homocystinurias, Br. J. Pharmacol., 176, 594, 10.1111/bph.14523 Morris, 2017, Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency, J. Inherit. Metab. Dis., 40, 49, 10.1007/s10545-016-9979-0 Behera, 2017, Homocysteine as a pathological biomarker for bone disease, J. Cell. Physiol., 232, 2704, 10.1002/jcp.25693 Behera, 2018, Hydrogen sulfide epigenetically mitigates bone loss through OPG/RANKL regulation during hyperhomocysteinemia in mice, Bone, 114, 90, 10.1016/j.bone.2018.06.009 Behera, 2018, Hydrogen sulfide promotes bone homeostasis by balancing inflammatory cytokine signaling in CBS-deficient mice through an epigenetic mechanism, Sci. Rep., 8, 10.1038/s41598-018-33149-9 Zhai, 2019, Hydrogen sulfide attenuates homocysteine-induced osteoblast dysfunction by inhibiting mitochondrial toxicity, J. Cell. Physiol., 234, 18602, 10.1002/jcp.28498 Halpin, 1984, Selenium deficiency and transsulfuration in the chick, J. Nutr., 114, 606, 10.1093/jn/114.3.606 Davis, 2000, Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and, J. Nutr., 130, 2903, 10.1093/jn/130.12.2903 Uthus, 2002, Selenium deficiency in Fisher-344 rats decreases plasma and tissue homocysteine concentrations and alters plasma homocysteine and cysteine redox status, J. Nutr., 132, 1122, 10.1093/jn/132.6.1122 Venn, 2003, Selenium supplements do not increase plasma total homocysteine concentrations in men and women, J. Nutr., 133, 418, 10.1093/jn/133.2.418 González, 2004, Serum selenium is associated with plasma homocysteine concentrations in elderly humans, J. Nutr., 134, 1736, 10.1093/jn/134.7.1736 Berry, 2020, Treatment-resistant schizophrenia: focus on the transsulfuration pathway, Rev. Neurosci., 31, 219, 10.1515/revneuro-2019-0057 Handy, 2005, Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation, J. Biol. Chem., 280, 15518, 10.1074/jbc.M501452200 Biermann, 2013, Bone Cancer, Nat. Comprehen. Cancer Netw., 11, 688, 10.6004/jnccn.2013.0088 Zhuang, 2018, Preconditioning with hydrogen sulfide prevents bone cancer pain in rats through a proliferator-activated receptor gamma/p38/Jun N-terminal kinase pathway, Exp. Biol. Med., 243, 57, 10.1177/1535370217740859 Distrutti, 2006, Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels, J. Pharmacol. Exp. Therapeut., 316, 325, 10.1124/jpet.105.091595 Distrutti, 2010, Hydrogen sulphide induces μ opioid receptor-dependent analgesia in a rodent model of visceral pain, Mol. Pain Pergolizzi, 2021, Opioid therapy in cancer patients and survivors at risk of addiction, misuse, or complex dependency, Front. Pain. Res., 2, 10.3389/fpain.2021.691720 Lipinski, 2005, Rationale for the treatment of cancer with sodium selenite, Med. Hypotheses, 64, 806, 10.1016/j.mehy.2004.10.012 Wang, 2012, Dual functional selenium-substituted hydroxyapatite, Interface Focus, 2, 378, 10.1098/rsfs.2012.0002 Wang, 2016, In vitro and in vivo mechanism of bone tumor inhibition by selenium-doped bone mineral nanoparticles, ACS Nano, 10, 9927, 10.1021/acsnano.6b03835 Hemalatha, 2014, Preparation and characterization of hydroxyapatite-coated selenium nanoparticles and their interaction with osteosarcoma (SaOS-2) cells, Acta Metall. Sin., 27, 1152, 10.1007/s40195-014-0153-0 Zhang, 2014, Synthesis and characterization of selenium substituted hydroxyapatite via a hydrothermal procedure, Mater. Lett., 134, 123, 10.1016/j.matlet.2014.07.072 Korowash, 2017, Selenium-substituted hydroxyapatite nanoparticles and their in vitro interaction on human bone marrow- and umbilical cord- derived mesenchymal stem cells, Interceram: Int. Ceram. Rev., 66, 244 Barbanente, 2021, Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy, J. Inorg. Biochem., 215, 10.1016/j.jinorgbio.2020.111334 Khan, 2019, Catechins-modified selenium-doped hydroxyapatite nanomaterials for improved osteosarcoma therapy through generation of reactive oxygen species, Front. Oncol., 9, 499, 10.3389/fonc.2019.00499 Yiannakopoulou, 2014, Interaction of green tea catechins with breast cancer endocrine treatment: a systematic review, Pharmacology, 94, 245, 10.1159/000369170 Cunningham, 2017, Fracture healing: a review of clinical, imaging and laboratory diagnostic options, Injury, 48, S69, 10.1016/j.injury.2017.04.020 Schindeler, 2008, Bone remodeling during fracture repair: the cellular picture, Semin. Cell Dev. Biol., 19, 459, 10.1016/j.semcdb.2008.07.004 Thomas, 2020 James, 2016, A review of the clinical side effects of bone morphogenetic protein-2, Tissue Eng. B Rev., 22, 284, 10.1089/ten.teb.2015.0357 Poynton, 2002, Safety profile for the clinical use of bone morphogenetic proteins in the spine, Spine, 27, S40, 10.1097/00007632-200208151-00010 Hettiaratchi, 2020, Heparin-mediated delivery of bone morphogenetic protein-2 improves spatial localization of bone regeneration, Sci. Adv., 6, 10.1126/sciadv.aay1240 Zheng, 2017, Cystathionine gamma-lyase-hydrogen sulfide induces runt-related transcription factor 2 sulfhydration, thereby increasing osteoblast activity to promote bone fracture healing, Antioxidants Redox Signal., 27, 742, 10.1089/ars.2016.6826 Song, 2020, Cystathionine gamma-lyase-H2S facilitates mandibular defect healing via inducing osteogenic differentiation of bone marrow mesenchymal stem cells, Arch. Oral Biol., 117, 10.1016/j.archoralbio.2020.104821 Jiang, 2015, GYY4137 promotes bone formation in a rabbit distraction osteogenesis model: a preliminary report, J. Oral Maxillofac. Surg., 73, 732 e1, 10.1016/j.joms.2014.11.012 Ming Yang, 2019, Baorong He, Treatment with hydrogen sulfide donor attenuates bone loss induced by modeled microgravity, Can. J. Physiol. Pharmacol., 97, 655, 10.1139/cjpp-2018-0521 Ibrahim, 2014, The effect of selenium and lycopene on oxidative stress in bone tissue in rats exposed to cadmium, Food Nutr. Sci., 5, 1420 Cagri Delilbasi, 2002, Belma Turan, Effects of selenium on the structure of the mandible in experimental diabetics, J. Oral Sci., 44, 85, 10.2334/josnusd.44.85 Raggio, 2018, Silk fibroin porous scaffolds loaded with a slow-releasing hydrogen sulfide agent (GYY4137) for applications of tissue engineering, ACS Biomater. Sci. Eng., 4, 2956, 10.1021/acsbiomaterials.8b00212 Gambari, 2019, Hydrogen sulfide-releasing silk fibroin scaffold for bone tissue engineering, Mater Sci Eng C Mater Biol Appl, 102, 471, 10.1016/j.msec.2019.04.039 Aksakal, 2018, Synthesizing selenium- and silver-substituted hydroxyapatite-based bone grafts and their effects on antibacterial efficiency and cell viability, Biomed. Tech., 63, 291, 10.1515/bmt-2017-0230 Whiteman, 2015, Phosphinodithioate and phosphoramidodithioate hydrogen sulfide donors, Handb. Exp. Pharmacol., 230, 337, 10.1007/978-3-319-18144-8_17 Fu, 2021, Sulforaphane alleviates hyperalgesia and enhances analgesic potency of morphine in rats with cancer-induced bone pain, Eur. J. Pharmacol., 909, 10.1016/j.ejphar.2021.174412 Pore, 2020, A novel sulforaphane-regulated gene network in suppression of breast cancer–induced osteolytic bone ResorptionSulforaphane inhibits osteoclastogenesis, Mol. Cancer Therapeut., 19, 420, 10.1158/1535-7163.MCT-19-0611 Luo, 2021, Sulforaphane inhibits osteoclastogenesis via suppression of the autophagic pathway, Molecules, 26, 347, 10.3390/molecules26020347 Thaler, 2016, Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate, J. Biol. Chem., 291, 6754, 10.1074/jbc.M115.678235 Gambari, 2020, Sulfurous thermal waters stimulate the osteogenic differentiation of human mesenchymal stromal cells - an in vitro study, Biomed. Pharmacother., 129, 10.1016/j.biopha.2020.110344 Levinn, 2020, Activatable small-molecule hydrogen sulfide donors, Antioxidants Redox Signal., 32, 96, 10.1089/ars.2019.7841 Levinn, 2019, Development and application of carbonyl sulfide-based donors for H2S delivery, Acc. Chem. Res., 52, 2723, 10.1021/acs.accounts.9b00315 Berkmann, 2020, Early pH changes in musculoskeletal tissues upon injury—aerobic catabolic pathway activity linked to inter-individual differences in local pH, Int. J. Mol. Sci., 21, 2513, 10.3390/ijms21072513 Zhao, 2016, Hydrogen sulfide donors activated by reactive oxygen species, Angew. Chem. Int. Ed., 55, 14638, 10.1002/anie.201608052 Gilbert, 2019, Development of acid-mediated H2S/COS donors that respond to a specific pH window, J. Org. Chem., 84, 14469, 10.1021/acs.joc.9b01873 Kang, 2016, pH-controlled hydrogen sulfide release for myocardial ischemia-reperfusion injury, J. Am. Chem. Soc., 138, 6336, 10.1021/jacs.6b01373 Schewe, 1995, Molecular actions of Ebselen-an antiinflammatory antioxidant, Gen. Pharmacol., 26, 1153, 10.1016/0306-3623(95)00003-J Santi, 2021, Ebselen and analogues: pharmacological properties and synthetic strategies for their preparation, Molecules, 26, 4230, 10.3390/molecules26144230 Kharma, 2019, Release of reactive selenium species from phthalic selenoanhydride in the presence of hydrogen sulfide and glutathione with implications for cancer research, New J. Chem., 43, 11771, 10.1039/C9NJ02245G Cerda, 2019, Dithioesters: simple, tunable, cysteine-selective H2S donors, Chem. Sci., 10, 1773, 10.1039/C8SC04683B Newton, 2021, Hydrolysis-based small-molecule hydrogen selenide (H2Se) donors for intracellular H2Se delivery, J. Am. Chem. Soc., 143, 19542, 10.1021/jacs.1c09525 Kang, 2022, Cysteine-activated small-molecule H2Se donors inspired by synthetic H2S donors, J. Am. Chem. Soc., 144, 3957, 10.1021/jacs.1c12006 Meng Lv, 2017, GYY4137 stimulates osteoblastic cell proliferation and differentiation via an ERK1/2-dependent anti-oxidant mechanism, Am. J. Trans. Res., 9, 1183 Lee, 2011, The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo, PLoS One, 6, 10.1371/journal.pone.0021077 Mo, 2018, Cystathionine gamma lyase-H2S contributes to osteoclastogenesis during bone remodeling induced by mechanical loading, Biochem. Biophys. Res. Commun., 501, 471, 10.1016/j.bbrc.2018.05.015 Hoeg, 2012, Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women, J. Clin. Endocrinol. Metab., 97, 4061, 10.1210/jc.2012-2121 Zheng, 2020, Anti-Oxidant and anti-endothelial dysfunctional properties of nano-selenium in vitro and in vivo of hyperhomocysteinemic rats, Int. J. Nanomed., 15, 4501, 10.2147/IJN.S255392